Max Healthcare Institute · NSE: MAXHEALTH · BSE: 543220
Q4 FY21 results · Jan–Mar 2021
Max Healthcare Institute reported revenue from operations of ₹801.86 crore and net profit of ₹69.69 crore for Q4 FY21 (Jan–Mar 2021), on a consolidated basis.
| Item | Q4 FY21 | Q4 FY20 | YoY | Q3 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 801.86 | — | — | 795.60 | +0.8% |
| Other income | 28.68 | — | — | 39.52 | −27.4% |
| Total income | 830.54 | — | — | 835.12 | −0.5% |
| Profit before tax | 104.47 | — | — | 104.89 | −0.4% |
| Net profit for the period | 69.69 | — | — | 90.36 | −22.9% |
| Attributable to shareholders of the company | 70.50 | — | — | 90.36 | −22.0% |
| EPS, basic (₹) | 0.76 | — | — | 1.00 | −24.0% |
| Net margin (%) | 8.7 | — | 11.4 |
| Item | Q4 FY21 | Q4 FY20 | YoY | Q3 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 330.80 | — | — | 346.13 | −4.4% |
| Other income | 25.05 | — | — | 25.27 | −0.9% |
| Total income | 355.85 | — | — | 371.40 | −4.2% |
| Profit before tax | 30.64 | — | — | 34.69 | −11.7% |
| Net profit for the period | 7.24 | — | — | 31.55 | −77.1% |
| EPS, basic (₹) | 0.08 | — | — | 0.35 | not comparable |
| Net margin (%) | 2.2 | — | 9.1 |
Consolidated
- Filed with BSE
- 29 May 2021, 17:12 IST
- Board meeting
- 28 May 2021
- Period
- 01 Jan 2021 to 31 Mar 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 29 May 2021, 17:12 IST
- Board meeting
- 28 May 2021
- Period
- 01 Jan 2021 to 31 Mar 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE